Natco Pharma Limited has informed the Exchange about change in designation of Senior Management Personnel
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has updated the designations of five senior management officials effective 18th July 2025. Mr. Sandeep Kumar is now Senior Vice President – QA, Mr. Rampalli Sriram is Senior Vice President – CRD, Mr. Mantri Prabhakar Rao is Vice President – IT & IS, Mr. N Chandrasekaran is Associate Vice President – Sales & Marketing (CND & Reach), and Mr. Amresh Kumar Trivedi is General Manager – Legal. The officials bring experience ranging from 15 to 32 years across pharma, R&D, IT, sales, and legal functions. This is a routine internal HR realignment with no change in board-level positions or key managerial personnel.
This is a routine internal designation change and is unlikely to have any material impact on the company's operations or stock price. No senior leadership exits or board-level changes are involved.